Pfaller MA, Diekema DJ. "Epidemiology of Invasive Candidiasis: a Persistent Public." Clinical Microbiology Reviews. 20(1): 133-163. 2007.

Borman AM, Petch R, Linton CJ, Palmer MD, Bridge PD, Johnson EM. "Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents". J. Clin. Microbiol. 46: 933-938. 2008.

Correia, A., P. Sampaio, S.James, and C. Pais. 2006. Candida bracarensis sp. nov., a novelanamorphic yeast species phenotypically similar to Candida glabrata.Int.J.Syst.Evol.Microbiol. 56:313-317.

Bartoli MZ, Cingolani B, Garcia-Effron G, Gamarra S. Análisis de métodosfenotípicos para la diferenciación de Candida dubliniensis y Candida albicans.Propuesta de una secuencia de identificación. Revista FABICIB. 2011. Vol 15:138-149.

Garcia-Effron,G., E. Canton, J. Peman, A. Dilger, E. Roma, and D. S. Perlin. 2011. Assessment of two new molecular methods for identification ofCandida parapsilosis sensu lato species. J.Clin.Microbiol. 49:3257-3261.

Ascioglu, S., J. H. Rex, et al. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin.Infect.Dis. 34:7-14.

 

Bantar C and Lopardo H. 1997.Urocultivo - Procesamiento, criterios de interpretación e informe., p. 1-13. In: Bantar C, Guardiano CA, and LopardoH (eds.), Apuntes de laboratorio. Laboratorio Britania SA, Buenos Aires.

 

dePauw, P. B., T. J. Walsh, et al. 2008. Reviseddefinitions of invasive fungal disease from the European Organization forResearch and Treatment of Cancer/Invasive Fungal Infections Cooperative Groupand the National Institute of Allergy and Infectious Diseases Mycoses StudyGroup (EORTC/MSG) Consensus Group. Clin.Infect.Dis. 46:1813-1821.

 

Ergon,M. C., T. ilknur, M. Yucesoy, and S. Ozkan. 2007. Candida spp. colonizationand serum anticandidal antibody levels in patients with chronic urticaria.Clin.Exp.Dermatol. 32:740-743.

 

Jarvis,W. R. 1996. The epidemiology of colonization. Infect.ControlHosp.Epidemiol. 17:47-52.

Jyonouchi,H., L. Geng, A. Cushing-Ruby, and I. M. Monteiro. 2010. Aberrant responsesto TLR agonists in pediatric IBD patients; the possible association withincreased production of Th1/Th17 cytokines in response to candida, a luminalantigen. Pediatr.Allergy Immunol. 21:e747-e755.

Kendler,M., W. Uter, A. Rueffer, R. Shimshoni, and E. Jecht. 2006. Comparison offecal microflora in children with atopic eczema/dermatitis syndrome accordingto IgE sensitization to food. Pediatr.Allergy Immunol. 17:141-147.

 

Khatib,R., J. A. Clark, L. E. Briski, and F. M. Wilson. 1995. Relevance ofculturing Candida species from intravascular catheters. J.Clin.Microbiol. 33:1635-1637.

 

Leon,M., M. Garcia, M. A. Herranz, V. Gonzalez, A. Martinez, F. Castillo, E. Andres,C. Leon, and J. Huet. 1998. Diagnosticvalue of Gram staining of peri-catheter skin and the connection in theprediction of intravascular-catheter-related bacteremia.Enferm.Infecc.Microbiol.Clin. 16:214-218.

Martin,G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology ofsepsis in the United States from 1979 through 2000. N.Engl.J.Med. 348:1546-1554.

McNeil,M. M., S. L. Nash, R. A. Hajjeh, M. A. Phelan, L. A. Conn, B. D. Plikaytis, andD. W. Warnock. 2001. Trends in mortality due to invasive mycotic diseasesin the United States, 1980-1997. Clin.Infect.Dis. 33:641-647.

Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin.Infect.Dis.39:309-317.

 

 

Home
Trabajos prácticos